Pulse Biosciences (PLSE) Operating Income (2015 - 2025)

Pulse Biosciences' Operating Income history runs 11 years deep, the most recent figure standing at -$20.4 million for Q3 2025.

• In Q3 2025, Operating Income fell 49.15% year-over-year to -$20.4 million; the TTM figure through Sep 2025 stood at -$78.9 million (down 62.68% YoY), while the FY2024 annual figure was -$56.3 million, down 29.11% from the prior year.
• Operating Income was -$20.4 million for Q3 2025 at Pulse Biosciences, roughly flat from -$20.3 million in the prior quarter.
• In the past five years, Operating Income ranged from a high of -$8.7 million in Q4 2022 to a low of -$20.4 million in Q3 2025.
• Historically, Operating Income has averaged -$14.7 million across 5 years, with a median of -$14.3 million in 2021.
• The sharpest annual moves came in 2023 and 2025: Operating Income surged 44.64% in 2023, then tumbled 72.91% in 2025.
• A 5-year view of Operating Income shows it stood at -$15.4 million in 2021, then soared by 43.25% to -$8.7 million in 2022, then plunged by 43.32% to -$12.5 million in 2023, then sank by 61.66% to -$20.3 million in 2024, then retreated by 0.52% to -$20.4 million in 2025.
• The last three Operating Income figures came in at -$20.4 million (Q3 2025), -$20.3 million (Q2 2025), and -$18.0 million (Q1 2025), per Business Quant data.